Rapidexon 2mg/ml Solution Fo Injection
DECHRA UK (PHARMACEUTICALS)
Rapidexon 2mg/ml Solution Fo Injection from DECHRA UK (PHARMACEUTICALS) is supplied as a solution for injection.
LEGAL CLASSIFICATION:POM-V
THIS MEDICINE REQUIRES A PRESCRIPTION.
This can be uploaded on this page or it can be sent to mail@vets4u.uk.
We also require information about you and your Pet for us to be able to dispense your Pets medicine, please provide us with all your up to date information in the Question boxes below.
A link to the Medicine SPC on the VMD Product database can be found here: VMD Product Database
UK Public Assessment Report: UKPAR (PDF)
Post-Authorisation Assessment Report: PAAR (PDF)
Active Ingredient(s)
Dexamethasone
Pack & Presentation
Form: Solution for injection · Pack size: 50ML
Suitable Species
Cats, Cattle, Dogs, Horses, Pigs
Indications
In horses, cattle, pigs, dogs and cats: Treatment of inflammatory or allergic conditions. In cattle: Treatment of primary ketosis (acetonaemia). Induction of parturition.
Storage & Shelf Life
Do not store above 25°C. Do not freeze. Keep the vial in the outer carton.
Owner Handling & Safety
In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. People with known hypersensitivity to the active substance or any of the excipients should avoid contact with the veterinary medicinal product. The veterinary medicinal product should not be administered by pregnant women.
Contraindications & Warnings
Except in emergency situations, do not use in animals suffering from diabetes mellitus, renal insufficiency, cardiac insufficiency, hyperadrenocorticism, or osteoporosis. Do not use in viral infections during the viraemic stage or in cases of systemic mycotic infections. Do not use in animals suffering from gastrointestinal or corneal ulcers, or demodicosis.
Use in Pregnancy & Lactation
Pregnancy and lactation: Do not administer the veterinary medicinal product in pregnant females, except where the intention is to induce parturition. Administration in early pregnancy is known to have caused foetal abnormalities in laboratory animals.
Regulatory Information
- Legal category: POM-V
- Marketing authorisation holder: Eurovet Animal Health BV, Handelsweg 25, 5531 AE Bladel, The Netherlands.
- MA number: GB: Vm 16849/4007 NI: VM 16849/3012
Important Notice
The information on this page is provided for general guidance only and does not replace the advice of a qualified veterinary surgeon. Always follow the directions provided on the product packaging and by your veterinary practice. If your animal's condition does not improve, worsens, or any side effects occur, contact your veterinary surgeon immediately.
